Next Article in Journal
Assessing Protein Content and Dimer Formation in the Bevacizumab Reference Product and Biosimilar Versions Marketed in Spain
Previous Article in Journal
The Intra-Articular Delivery of a Low-Dose Adeno-Associated Virus-IL-1 Receptor Antagonist Vector Alleviates the Progress of Arthritis in an Osteoarthritis Rat Model
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(12), 1519; https://doi.org/10.3390/pharmaceutics16121519
Action Date Notes Link
article html file updated 14 September 2025 13:56 CEST Update https://www.mdpi.com/1999-4923/16/12/1519/html
article html file updated 28 August 2025 03:55 CEST Update -
article html file updated 30 June 2025 19:18 CEST Update -
article html file updated 26 November 2024 07:46 CET Original file -
article supplementary file uploaded. 26 November 2024 07:41 CET - https://www.mdpi.com/1999-4923/16/12/1519#supplementary
article pdf uploaded. 26 November 2024 07:41 CET Version of Record https://www.mdpi.com/1999-4923/16/12/1519/pdf
article xml uploaded. 26 November 2024 07:41 CET Update https://www.mdpi.com/1999-4923/16/12/1519/xml
article xml file uploaded 26 November 2024 07:41 CET Original file -
Back to TopTop